공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

파킨슨병용 뇌심부자극요법(DBS) 시장 규모, 점유율, 동향 분석 : 제품(싱글 채널형, 듀얼 채널형), 최종사용(병원, ASC), 지역별 분석, 부문 예측(2020-2028년)

Deep Brain Stimulation in Parkinson´s Disease Market Size, Share & Trends Analysis Report By Product (Single Channel, Dual Channel), By End Use (Hospitals, ASCs), By Region, And Segment Forecasts, 2020 - 2028

리서치사 Grand View Research, Inc.
발행일 2020년 06월 상품 코드 948017
페이지 정보 영문 96 Pages
가격
US $ 5,950 ₩ 6,584,000 Unprintable PDF (Single User License)
US $ 6,950 ₩ 7,690,000 Printable PDF (5-User License)
US $ 8,950 ₩ 9,904,000 Printable PDF (Enterprise License)


파킨슨병용 뇌심부자극요법(DBS) 시장 규모, 점유율, 동향 분석 : 제품(싱글 채널형, 듀얼 채널형), 최종사용(병원, ASC), 지역별 분석, 부문 예측(2020-2028년) Deep Brain Stimulation in Parkinson´s Disease Market Size, Share & Trends Analysis Report By Product (Single Channel, Dual Channel), By End Use (Hospitals, ASCs), By Region, And Segment Forecasts, 2020 - 2028
발행일 : 2020년 06월 페이지 정보 : 영문 96 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 파킨슨병용 뇌심부자극요법(DBS) 시장 규모는 2028년까지 14억 2,000만 달러에 달할 것으로 예측되며, 2020-2028년의 예측기간 중 8.5%의 CAGR로 확대될 전망입니다. 파킨슨병(PD)과 PD용 뇌심부자극에 대한 인식 상승이 시장을 견인하고 있습니다. 파킨슨병 유병률 상승에 의해 대체요법으로서 뇌심부자극기의 수요가 증가하고 있습니다.

세계의 파킨슨병용 뇌심부자극요법(DBS) 시장에 대해 조사했으며, 현재 시장 동향, 각 부문·지역별 시장 분석과 예측 및 주요 기업 개요 등을 제공합니다.

제1장 조사 방법과 범위

제2장 주요 요약

제3장 규제·정치적 요인

  • 규제 상황
  • 정치 정세, 현재 및 향후 시나리오

제4장 파킨슨병용 뇌심부자극요법 시장 부문 분석 : 제품별

  • 정의와 범위
  • 시장 점유율 분석 : 제품별
  • 부문 대시보드
  • 세계의 파킨슨병용 뇌심부자극요법 시장 : 제품별
  • 시장 규모와 예측 및 동향 분석

제5장 파킨슨병용 뇌심부자극요법 시장 부문 분석 : 최종사용별

  • 정의와 범위
  • 시장 점유율 분석 : 최종사용별
  • 부문 대시보드
  • 세계의 파킨슨병용 뇌심부자극요법 시장 : 최종사용별
  • 시장 규모와 예측 및 동향 분석

제6장 파킨슨병용 뇌심부자극요법 시장 : 지역 시장 분석, 제품별, 최종사용별

  • 정의와 범위
  • 시장 점유율 분석 : 지역별
  • 지역 시장 현황
  • 시장 규모와 예측, 수량 기준 및 동향 분석
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제7장 경쟁 상황

  • 세계 시장 점유율 분석
  • 제품/기술 파이프라인 분석과 새로운 혁신
  • 기업 개요
KSM 20.07.21

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. Phase 1 Clinical Trials
  • Table 4. Phase 2 Clinical Trials
  • Table 5. Phase 3 Clinical Trials
  • Table 6. Phase 4 Clinical Trials
  • Table 7. North America Deep brain stimulation in Parkinson's disease market, by country, 2016 - 2028 (USD Million)
  • Table 8. North America Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 9. North America Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 10. U.S. Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 11. U.S. Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 12. Canada Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 13. Canada Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 14. Europe Deep brain stimulation in Parkinson's disease market, by country, 2016 - 2028 (USD Million)
  • Table 15. Europe Deep brain stimulation in Parkinson's disease market, by product design, 2016 - 2028 (USD Million)
  • Table 16. Europe Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 17. U.K. Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 18. U.K. Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 19. Germany Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 20. Germany Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 21. France Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 22. France Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 23. Italy Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 24. Italy Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 25. Spain Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 26. Spain Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 27. Asia Pacific Deep brain stimulation in Parkinson's disease market, by country, 2016 - 2028 (USD Million)
  • Table 28. Asia Pacific Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 29. Asia Pacific Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 30. China Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 31. China Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 32. Japan Deep brain stimulation in Parkinson's disease market, by product design, 2016 - 2028 (USD Million)
  • Table 33. Japan Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 34. Japan Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 35. Latin America Deep brain stimulation in Parkinson's disease market, by country, 2016 - 2028 (USD Million)
  • Table 36. Latin America Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 37. Latin America Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 38. Brazil Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 39. Brazil Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 40. Mexico Deep brain stimulation in Parkinson's disease market, by product design, 2016 - 2028 (USD Million)
  • Table 41. Mexico Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 42. Mexico Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 43. Middle East & Africa Deep brain stimulation in Parkinson's disease market, by country, 2016 - 2028 (USD Million)
  • Table 44. Middle East & Africa Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 45. Middle East & Africa Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 46. South Africa Deep brain stimulation in Parkinson's disease market, by product design, 2016 - 2028 (USD Million)
  • Table 47. South Africa Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 48. South Africa Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)
  • Table 49. Saudi Arabia Deep brain stimulation in Parkinson's disease market, by product, 2016 - 2028 (USD Million)
  • Table 50. Saudi Arabia Deep brain stimulation in Parkinson's disease market, by end use, 2016 - 2028 (USD Million)

List of Figures

  • Fig 1. Deep brain stimulation in Parkinson's disease market segmentation
  • Fig 2. Market research process
  • Fig 3. Information procurement
  • Fig 4. Primary research pattern
  • Fig 5. Market research approaches
  • Fig 6. Value-chain-based sizing & forecasting
  • Fig 7. QFD modeling for market share assessment
  • Fig 8. Market formulation & validation
  • Fig 9. Market outlook (2019)
  • Fig 10. Segment Outlook
  • Fig 11. Strategy framework
  • Fig 12. Penetration & growth prospect mapping
  • Fig 13. Consumer behavior analysis
  • Fig 14. Market driver relevance analysis (Current & future impact)
  • Fig 15. Market restraint relevance analysis (Current & future impact)
  • Fig 16. Porter's five forces analysis
  • Fig 17. SWOT analysis, by factor (political & legal, economic and technological)
  • Fig 18. Deep brain stimulation in Parkinson's disease market: Product movement analysis
  • Fig 19. Segment dashboard
  • Fig 20. Deep brain stimulation in Parkinson's disease market product outlook: Key takeaways
  • Fig 21. Single channel deep brain stimulator market, 2016 - 2028 (USD Million)
  • Fig 22. Dual channel deep brain stimulator market, 2016 - 2028 (USD Million)
  • Fig 23. Deep brain stimulation in Parkinson's disease market end use outlook: Key takeaways
  • Fig 24. Hospitals market, 2016 - 2028 (USD Million)
  • Fig 25. Neurology clinics market, 2016 - 2028 (USD Million)
  • Fig 26. Ambulatory surgical centers market, 2016 - 2028 (USD Million)
  • Fig 27. Research centers market, 2016 - 2028 (USD Million)
  • Fig 28. Regional outlook, 2019 & 2028
  • Fig 29. Regional market dashboard
  • Fig 30. Regional market place: Key takeaways
  • Fig 31. North America Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 32. U.S. Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 33. Canada Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 34. Europe Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 35. U.K. Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 36. Germany Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 37. France Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 38. Italy Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 39. Spain Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 40. Asia Pacific Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 41. Japan Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 42. China (Mainland) Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 43. Latin America Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 44. Brazil Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 45. Mexico Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 46. MEA Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 47. South Africa Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)
  • Fig 48. Saudi Arabia Deep brain stimulation in Parkinson's disease market, 2016 - 2028 (USD Million)

Deep Brain Stimulation In Parkinson's Disease Market Growth & Trends

The global deep brain stimulation in parkinson's disease market size is anticipated to reach USD 1.42 billion by 2028, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.5% from 2020 to 2028. Surge in the incidence of Parkinson's Disease (PD) and growing awareness about the deep brain stimulation in PD are driving the market.

Rising prevalence of Parkinson's disease has raised the demand for deep brain stimulators as an alternative therapy. Deep brain stimulation has been proved to play an important role in providing therapeutic solutions for the symptoms of Parkinson's disease, which is expected to fuel the market growth during the forecast period.

Moreover, increasing demand for minimally invasive therapies due to improved patient outcomes is a high impact rendering driver for this market. This is due to high cost efficiency, minimal pain, safety, short duration of hospital stays, speedy recovery, and few cases of post-surgical problems. These key factors are anticipated to raise the demand for deep brain stimulators over the forecast period.

In addition, technological advancements by the key players for the improved postoperative outcomes and reduced adverse effects in the treatment of PD symptoms are anticipated to raise the demand for deep brain stimulation. For instance, in January 2020, Abbott's Infinity deep brain stimulation system has secured expanded indication approval from the FDA for the treatment of PD. This system will allow to target patients' specific area of the brain called internal globus pallidus (GPi), which is associated with Parkinson's disease symptoms.

Deep Brain Stimulation In Parkinson's Disease Market Report Highlights

The dual channel segment dominated the market with the share of 57.2% in 2019 owing to its increasing adoption by neurosurgeons as it is highly effective in reducing patient tremors

On the basis of end use, hospitals dominated the market with a share of 52.1% in 2019 since deep brain stimulation procedures are the most complicated and critical surgeries that are performed in hospitals due to availability of high quality and durable equipment

North America dominated the market with a revenue share of 52.3% in 2019 owing to prevalence of psychological disorders and presence of well-established healthcare facilities in the region.

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Product
    • 1.1.2 End Use
    • 1.1.3 Regional Scope
    • 1.1.4 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis (Model 1)
      • 1.7.1.1 Approach 1: Commodity Flow Approach
    • 1.7.2 Volume Price Analysis (Model 2)
      • 1.7.2.1 Approach 2: Volume Price Analysis
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Primary Sources
  • 1.10 List Of Abbreviations
  • 1.11 Objectives
    • 1.11.1 Objective 1
    • 1.11.2 Objective 2
    • 1.11.3 Objective 3
    • 1.11.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Penetration & Growth Prospect Mapping
  • 2.3 Major Deals And Strategic Alliances Analysis
    • 2.3.1 Strategic Initiatives And Outcome Analysis
  • 2.4 Market Entry Strategies
    • 2.4.1 Innovation/Oem
    • 2.4.2 Product Launch
  • 2.5 Consumer Behavior Analysis
  • 2.6 Market Dynamics
    • 2.6.1 Market Driver Analysis
      • 2.6.1.1 Increasing Prevalence Of Parkinson's Disease
      • 2.6.1.2 Rapidly Aging Population
      • 2.6.1.3 Technological Advancement
      • 2.6.1.4 Increasing Preference For Targeted Therapy Approach
    • 2.6.2 Market Restraints Analysis
      • 2.6.2.1 Complex Regulatory Framework
      • 2.6.2.2 Risks Of Dbs Surgery
    • 2.6.3 Market Challenges Analysis
      • 2.6.3.1 Lack Of Infrastructure In Developing Economies
  • 2.7 Deep Brain Stimulation In Parkinson's Disease Market: Market Analysis Tools
    • 2.7.1 Industry Analysis - Porter's
    • 2.7.2 Swot Analysis, By Pest
  • 2.8 Political And Legal
    • 2.8.1 Strengths
    • 2.8.2 Weaknesses
    • 2.8.3 Opportunities
    • 2.8.4 Threats
  • 2.9 Economic
    • 2.9.1 Strengths
    • 2.9.2 Weaknesses
    • 2.9.3 Opportunities
    • 2.9.4 Threats
  • 2.10 Technological
    • 2.10.1 Strengths
    • 2.10.2 Weaknesses
    • 2.10.3 Opportunities
    • 2.10.4 Threats
  • 2.11 Deep Brain Stimulation In Parkinson's Disease Market, By Product: Comparative Analysis

Chapter 3 Regulatory And Political Forces

  • 3.1 Regulatory Landscape
    • 3.1.1 List Of Regulations, By Country
  • 3.2 Political Landscape, Current And Future Scenario
    • 3.2.1 North America
    • 3.2.2 Europe
    • 3.2.3 Asia Pacific
    • 3.2.4 Latin America
    • 3.2.5 Middle East And Africa

Chapter 4 Deep Brain Stimulation In Parkinson's Disease Market: Segment Analysis, By Product, 2016 - 2028 (USD Million)

  • 4.1 Definition And Scope
  • 4.2 Product Market Share Analysis, 2019 & 2028
  • 4.3 Segment Dashboard
  • 4.4 Global Deep Brain Stimulation In Parkinson's Disease Market, By Product, 2016 To 2028
  • 4.5 Market Size & Forecasts And Trend Analyses, 2016 To 2028
    • 4.5.1 Single Channel Deep Brain Stimulator
      • 4.5.1.1 Single Channel Deep Brain Stimulator Market, 2016 - 2028 (USD Million)
    • 4.5.2 Dual Channel Deep Brain Stimulator
      • 4.5.2.1 Dual Channel Deep Brain Stimulator Market, 2016 - 2028 (USD Million)

Chapter 5 Deep Brain Stimulation In Parkinson's Disease Market: Segment Analysis, By End Use, 2016 - 2028 (USD Million)

  • 5.1 Definition And Scope
  • 5.2 End Use Market Share Analysis, 2019 & 2028
  • 5.3 Segment Dashboard
  • 5.4 Global Deep Brain Stimulation In Parkinson's Disease Market, By End Use, 2016 To 2028
  • 5.5 Market Size & Forecasts And Trend Analyses, 2016 To 2028
    • 5.5.1 Hospitals
      • 5.5.1.1 Hospitals Market, 2016 - 2028 (USD Million)
    • 5.5.2 Neurology Clinics
      • 5.5.2.1 Neurology Clinics Market, 2016 - 2028 (USD Million)
    • 5.5.3 Ambulatory Surgical Centers
      • 5.5.3.1 Ambulatory Surgical Centers Market, 2016 - 2028 (USD Million)
    • 5.5.4 Research Centers
      • 5.5.4.1 Research Centers Market, 2016 - 2028 (USD Million)

Chapter 6 Deep Brain Stimulation In Parkinson's Disease Market: Regional Market Analysis, By Product, By End Use, 2016 - 2028 (USD Million)

  • 6.1 Definition & Scope
  • 6.2 Regional Market Share Analysis, 2019 & 2028
  • 6.3 Regional Market Snapshot
  • 6.4 Market Size, & Forecasts, Volume And Trend Analysis, 2016 To 2028
  • 6.5 North America
    • 6.5.1 North America Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
    • 6.5.2 U.S.
      • 6.5.2.1 U.S. Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
    • 6.5.3 Canada
      • 6.5.3.1 Canada Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
  • 6.6 Europe
    • 6.6.1 Europe Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
    • 6.6.2 U.K.
      • 6.6.2.1 U.K. Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
    • 6.6.3 Germany
      • 6.6.3.1 Germany Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
    • 6.6.4 France
      • 6.6.4.1 France Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
    • 6.6.5 Italy
      • 6.6.5.1 Italy Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
    • 6.6.6 Spain
      • 6.6.6.1 Spain Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
  • 6.7 Asia Pacific
    • 6.7.1 Asia Pacific Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
    • 6.7.2 Japan
      • 6.7.2.1 Japan Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
    • 6.7.3 China
      • 6.7.3.1 China Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
  • 6.8 Latin America
    • 6.8.1 Latin America Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
    • 6.8.2 Brazil
      • 6.7.2.1 Brazil Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
    • 6.8.3 Mexico
      • 6.8.3.1 Mexico Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
  • 6.9 Middle East And Africa
    • 6.9.1 Middle East And Africa Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
    • 6.9.2 Saudi Arabia
      • 6.9.2.1 Saudi Arabia Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)
    • 6.9.3 South Africa
      • 6.9.3.1 South Africa Deep Brain Stimulation In Parkinson's Disease Market, 2016 - 2028 (USD Million)

Chapter 7 Deep Brain Stimulation In Parkinson's Disease Market - Competitive Analysis

  • 7.1 Global Market Share Analysis (2019)
  • 7.2 Product/Technology Pipeline Analysis (2020 To 2028) And New Innovations
    • 7.2.1 Product Pipeline Analysis
    • 7.2.2 Ongoing Research/ Innovations
  • 7.3 Company Profiles
    • 7.3.1 ABBOTT (ST. JUDE MEDICAL)
      • 7.3.1.1 Company Overview
      • 7.3.1.2 Financial Performance
      • 7.3.1.3 Product Benchmarking
      • 7.3.1.3.1 Product Price
      • 7.3.1.4 Strategic Initiatives
    • 7.3.2 MEDTRONIC
      • 7.3.2.1 Company Overview
      • 7.3.2.2 Financial Performance
      • 7.3.2.3 Product/Service Benchmarking
      • 7.3.2.3.1 Product Price
      • 7.3.2.4 Strategic Initiatives
    • 7.3.3 BOSTON SCIENTIFIC CORPORATION
      • 7.3.3.1 Company Overview
      • 7.3.3.2 Financial Performance
      • 7.3.3.3 Product/Service Benchmarking
      • 7.3.3.3.1 Product Price
      • 7.3.3.4 Strategic Initiatives
Back to Top
전화 문의
F A Q